Kentucky Retirement Systems Insurance Trust Fund lowered its stake in shares of Humana Inc. (NYSE:HUM – Free Report) by 8.3% in the third quarter, HoldingsChannel reports. The fund owned 3,565 shares of the insurance provider’s stock after selling 322 shares during the quarter. Kentucky Retirement Systems Insurance Trust Fund’s holdings in Humana were worth $1,129,000 at the end of the most recent quarter.
Other large investors have also modified their holdings of the company. Creative Financial Designs Inc. ADV increased its position in Humana by 244.0% during the third quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider’s stock worth $27,000 after purchasing an additional 61 shares during the last quarter. CarsonAllaria Wealth Management Ltd. increased its holdings in shares of Humana by 111.4% during the 2nd quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock worth $28,000 after buying an additional 39 shares during the last quarter. Atwood & Palmer Inc. purchased a new position in shares of Humana in the 3rd quarter worth $29,000. Ashton Thomas Securities LLC acquired a new position in Humana in the third quarter valued at $31,000. Finally, Your Advocates Ltd. LLP grew its position in Humana by 81.8% during the third quarter. Your Advocates Ltd. LLP now owns 100 shares of the insurance provider’s stock valued at $32,000 after acquiring an additional 45 shares during the period. 92.38% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
Several research firms recently weighed in on HUM. Barclays lifted their target price on shares of Humana from $250.00 to $253.00 and gave the company an “equal weight” rating in a report on Thursday, October 31st. Royal Bank of Canada decreased their target price on Humana from $400.00 to $265.00 and set an “outperform” rating for the company in a research report on Tuesday, October 8th. Piper Sandler downgraded Humana from an “overweight” rating to a “neutral” rating and dropped their target price for the company from $392.00 to $274.00 in a report on Thursday, October 3rd. JPMorgan Chase & Co. boosted their price target on Humana from $332.00 to $396.00 and gave the stock a “neutral” rating in a research report on Wednesday, August 21st. Finally, Stephens reaffirmed an “equal weight” rating and issued a $250.00 price objective on shares of Humana in a research report on Wednesday, October 9th. Twenty analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $315.86.
Humana Trading Down 2.6 %
Shares of NYSE HUM opened at $275.67 on Monday. The company has a market cap of $33.19 billion, a price-to-earnings ratio of 24.42, a price-to-earnings-growth ratio of 2.17 and a beta of 0.52. The stock’s 50 day simple moving average is $281.36 and its 200 day simple moving average is $331.94. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.67. Humana Inc. has a 12-month low of $213.31 and a 12-month high of $527.18.
Humana (NYSE:HUM – Get Free Report) last released its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share for the quarter, beating analysts’ consensus estimates of $3.48 by $0.68. Humana had a return on equity of 13.20% and a net margin of 1.18%. The company had revenue of $29.30 billion for the quarter, compared to analysts’ expectations of $28.66 billion. Equities research analysts expect that Humana Inc. will post 15.86 EPS for the current year.
Humana Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Tuesday, December 31st will be given a $0.885 dividend. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $3.54 dividend on an annualized basis and a yield of 1.28%. Humana’s dividend payout ratio is presently 31.36%.
Humana Profile
Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
Featured Articles
- Five stocks we like better than Humana
- Health Care Stocks Explained: Why You Might Want to Invest
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- ESG Stocks, What Investors Should Know
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM – Free Report).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.